B-type natriuretic peptide efficacy compared to fragmented QRS for diastolic dysfunction screening in patients with type 2 diabetes
A BNP level ≥ 35 pg/mL in non-overweight individuals may be a reliable LVDD marker. Additionally, fQRS was more effective than BNP in diagnosing LVDD irrespective of the patient's weight. fQRS can complement BNP in the early detection of LVDD, especially in overweight patients, potentially improving early detection and mitigating progression to heart failure with preserved EF in patients with type 2 diabetes.
Authors
- Hideki Origasa (ORCID: https://orcid.org/0000-0002-9618-7361)
- Daisuke Chujo (ORCID: https://orcid.org/0000-0001-7727-6310)
- Kunimasa Yagi (ORCID: https://orcid.org/0000-0002-6805-6428)
- Hisae Honoki
- Shiho Fujisaka (ORCID: https://orcid.org/0000-0003-0554-9003)
- Isao Usui (ORCID: https://orcid.org/0000-0002-4720-4882)
- Atsushi Nohara (ORCID: https://orcid.org/0000-0002-2586-5727)
- Akiko Takikawa
- Jianhui Liu (ORCID: https://orcid.org/0000-0001-8921-7350)
- Hayato Tada (ORCID: https://orcid.org/0000-0002-3357-1809)
- Asako Enkaku Shirozu
Institutions
- Kanazawa University (JP)
- Shiga University (JP)
- Ningbo Medical Center Lihuili Hospital (CN)
- Ishikawa Prefectural Central Hospital (JP)
- Kanazawa Medical University Hospital (JP)
- Toyama University Hospital (JP)
- Dokkyo Medical University (JP)
Publication Details
- Journal
- World Journal of Diabetes
- Published
- 2025-02-28
- DOI
- https://doi.org/10.4239/wjd.v16.i4.103551
- Primary Topic
- Cardiovascular Function and Risk Factors
- Type
- article
- Field-Weighted Citation Impact
- 0.00